(BAS) BASF SE - Ratings and Ratios
Petrochemicals, Intermediates, Advanced Materials, Catalysts, Fungicides
BAS EPS (Earnings per Share)
BAS Revenue
Description: BAS BASF SE
BASF SE is a global chemical company operating through six distinct segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The companys diverse portfolio caters to various industries, including automotive, construction, electronics, and agriculture, providing a range of products such as petrochemicals, advanced materials, and crop protection solutions.
From a financial perspective, BASF SE has a market capitalization of approximately €38.2 billion, with a forward P/E ratio of 14.53, indicating a relatively stable valuation. The companys Return on Equity (RoE) stands at 2.09%, suggesting a modest return on shareholder equity. To further analyze the companys financial health, we can examine additional KPIs such as Debt-to-Equity ratio, Interest Coverage ratio, and Operating Margin. For instance, BASF SEs Debt-to-Equity ratio is around 0.43, indicating a relatively conservative debt profile. The companys Operating Margin is approximately 10.3%, reflecting its ability to maintain profitability amidst varying market conditions.
In terms of growth prospects, BASF SEs Agricultural Solutions segment is poised to benefit from the increasing demand for sustainable agricultural practices and digital farming solutions. The companys Nutrition & Care segment is also expected to drive growth, driven by the rising demand for high-quality ingredients in the consumer goods sector. To gauge the companys growth potential, we can examine metrics such as Revenue Growth Rate and Earnings Per Share (EPS) growth. BASF SEs 3-year Revenue Growth Rate is around 4.5%, while its EPS growth rate is approximately 6.2%, indicating a steady improvement in profitability.
Overall, BASF SEs diversified business model, global presence, and commitment to innovation position the company for long-term success. By analyzing key financial metrics and industry trends, investors can make informed decisions about the companys potential for future growth and returns.
BAS Stock Overview
| Market Cap in USD | 45,903m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception |
BAS Stock Ratings
| Growth Rating | 14.8% |
| Fundamental | 43.0% |
| Dividend Rating | 45.2% |
| Return 12m vs S&P 500 | -11.1% |
| Analyst Rating | - |
BAS Dividends
| Dividend Yield 12m | 5.18% |
| Yield on Cost 5y | 5.67% |
| Annual Growth 5y | 0.60% |
| Payout Consistency | 98.5% |
| Payout Ratio | 87.6% |
BAS Growth Ratios
| Growth Correlation 3m | 64.2% |
| Growth Correlation 12m | 15.7% |
| Growth Correlation 5y | -21.2% |
| CAGR 5y | 9.32% |
| CAGR/Max DD 3y | 0.34 |
| CAGR/Mean DD 3y | 0.89 |
| Sharpe Ratio 12m | -1.11 |
| Alpha | 0.03 |
| Beta | 0.937 |
| Volatility | 24.49% |
| Current Volume | 1457k |
| Average Volume 20d | 1775k |
| Stop Loss | 42.3 (-3.1%) |
| Signal | -0.47 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (388.0m TTM) > 0 and > 6% of Revenue (6% = 3.89b TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -2.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.18% (prev 21.20%; Δ -0.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 6.11b > Net Income 388.0m (YES >=105%, WARN >=100%) |
| Net Debt (21.34b) to EBITDA (7.24b) ratio: 2.95 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (892.5m) change vs 12m ago -0.00% (target <= -2.0% for YES) |
| Gross Margin 26.21% (prev 25.21%; Δ 1.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 80.90% (prev 79.17%; Δ 1.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.28 (EBITDA TTM 7.24b / Interest Expense TTM 1.16b) >= 6 (WARN >= 3) |
Altman Z'' 3.32
| (A) 0.18 = (Total Current Assets 31.90b - Total Current Liabilities 18.18b) / Total Assets 77.67b |
| (B) 0.38 = Retained Earnings (Balance) 29.75b / Total Assets 77.67b |
| (C) 0.03 = EBIT TTM 2.64b / Avg Total Assets 80.06b |
| (D) 0.66 = Book Value of Equity 29.22b / Total Liabilities 44.16b |
| Total Rating: 3.32 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.95
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield 0.77% = 0.39 |
| 3. FCF Margin 0.72% = 0.18 |
| 4. Debt/Equity 0.74 = 2.24 |
| 5. Debt/Ebitda 3.29 = -2.13 |
| 6. ROIC - WACC (= -2.95)% = -3.68 |
| 7. RoE 1.12% = 0.09 |
| 8. Rev. Trend -73.58% = -5.52 |
| 9. EPS Trend 17.65% = 0.88 |
What is the price of BAS shares?
Over the past week, the price has changed by +0.34%, over one month by -5.80%, over three months by +2.92% and over the past year by +5.59%.
Is BASF SE a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BAS is around 42.72 EUR . This means that BAS is currently overvalued and has a potential downside of -2.15%.
Is BAS a buy, sell or hold?
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.3 | 15.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 46.7 | 6.8% |
BAS Fundamental Data Overview
Market Cap EUR = 39.15b (39.15b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 2.52b EUR (last quarter)
P/E Trailing = 102.0
P/E Forward = 14.6413
P/S = 0.6044
P/B = 1.2123
P/EG = 0.8911
Beta = 1.13
Revenue TTM = 64.77b EUR
EBIT TTM = 2.64b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.96b EUR (from longTermDebt, last quarter)
Short Term Debt = 4.89b EUR (from shortTermDebt, last quarter)
Debt = 23.85b EUR (Calculated: Short Term 4.89b + Long Term 18.96b)
Net Debt = 21.34b EUR (from netDebt column, last quarter)
Enterprise Value = 60.48b EUR (39.15b + Debt 23.85b - CCE 2.52b)
Interest Coverage Ratio = 2.28 (Ebit TTM 2.64b / Interest Expense TTM 1.16b)
FCF Yield = 0.77% (FCF TTM 468.0m / Enterprise Value 60.48b)
FCF Margin = 0.72% (FCF TTM 468.0m / Revenue TTM 64.77b)
Net Margin = 0.60% (Net Income TTM 388.0m / Revenue TTM 64.77b)
Gross Margin = 26.21% ((Revenue TTM 64.77b - Cost of Revenue TTM 47.79b) / Revenue TTM)
Tobins Q-Ratio = 2.07 (Enterprise Value 60.48b / Book Value Of Equity 29.22b)
Interest Expense / Debt = 1.08% (Interest Expense 257.0m / Debt 23.85b)
Taxrate = 29.77% (616.0m / 2.07b)
NOPAT = 1.85b (EBIT 2.64b * (1 - 29.77%))
Current Ratio = 1.75 (Total Current Assets 31.90b / Total Current Liabilities 18.18b)
Debt / Equity = 0.74 (Debt 23.85b / last Quarter total Stockholder Equity 32.36b)
Debt / EBITDA = 3.29 (Net Debt 21.34b / EBITDA 7.24b)
Debt / FCF = 50.97 (Debt 23.85b / FCF TTM 468.0m)
Total Stockholder Equity = 34.69b (last 4 quarters mean)
RoA = 0.50% (Net Income 388.0m, Total Assets 77.67b )
RoE = 1.12% (Net Income TTM 388.0m / Total Stockholder Equity 34.69b)
RoCE = 4.92% (Ebit 2.64b / (Equity 34.69b + L.T.Debt 18.96b))
RoIC = 3.23% (NOPAT 1.85b / Invested Capital 57.51b)
WACC = 6.17% (E(39.15b)/V(63.00b) * Re(9.47%)) + (D(23.85b)/V(63.00b) * Rd(1.08%) * (1-Tc(0.30)))
Shares Correlation 3-Years: -67.00 | Cagr: -0.05%
Discount Rate = 9.47% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 70.96% ; FCFE base≈1.36b ; Y1≈1.20b ; Y5≈996.4m
Fair Price DCF = 15.93 (DCF Value 14.22b / Shares Outstanding 892.5m; 5y FCF grow -14.37% → 3.0% )
EPS Correlation: 17.65 | EPS CAGR: -66.15% | SUE: -0.02 | # QB: 0
Revenue Correlation: -73.58 | Revenue CAGR: -11.33% | SUE: N/A | # QB: None